Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Panbela Therapeutics Inc.
Sponsor

Panbela Therapeutics Inc.

United States 712 Vista Boulevard 305, 55387-4559, United States

About the sponsor

Panbela Therapeutics Inc. is focused on clinical research in metastatic pancreatic ductal adenocarcinoma, with interest in treatment approaches for advanced disease affecting the pancreas and surrounding tissues.

  • Metastatic pancreatic ductal adenocarcinoma
  • Advanced pancreatic malignancy
  • Solid tumour oncology

The sponsor’s research activity is directed toward outcomes in pancreatic cancer, particularly in patients with disseminated disease requiring systemic therapy.

About Specializations

Panbela Therapeutics Inc. runs clinical trials in conditions such as Ductal adenocarcinoma of pancreas, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Ductal adenocarcinoma of pancreas

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Panbela Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.